U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade
Notified -
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-10-09, 17:05
Email: info@10toptenreviews.com
10 Top Ten Reviews is part of VSG Solution JSC, an international media group and leading digital publisher.
© 2021 - 10TopTenReiews All Rights Reserved.